[1] Targher G. Non-alcoholic fatty liver disease as driving force in coronary heart disease? Gut, 2017, 66:213.
[2] Ye P, Qu CF, Hu XL. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. Tumor Biol, 2016, 37:6893-6904.
[3] Wang J, Li YC, Deng M, et al. Serum insulin-like growth factor 1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget, 2017,8:81098-81108.
[4] Liang S, Cheng X, Hu Y, et al. Insulin-like growth factor 1 and metabolic parameters are with nonalcoholic fatty liver disease in obese children and adolescents. ActaPaediatrica, 2017, 106:298-303.
[5] Völzke H, Nauck M, Rettig R, et al. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. European Journal of Endocrinology, 2009, 161:705-713.
[6] Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med, 2017, 377:2063-2072.
[7] Yan XD, Yao M, Wang L, et al. Overexpression of insulin-like growth factor-1 receptor as a pertinent biomarker for hepa-tocytes malignant transformation. World J Gastroenterol, 2013, 19:6084-6092.
[8] Svegliatibaroni G, Ridolfi F, Di SA, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology, 1999, 29:1743-1751.
[9] Takahashi Y, Iida K, Takahashi K, et al. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology, 2007, 132:938-943.
[10] Liu Z, Cordoba-Chacon J, Kineman RD, et al. Growth hormone control of hepatic lipid metabolism. Diabetes, 2016, 65:3598-3609.
[11] Borrelli A, Bonelli P, Tuccillo FM, et al. Role of gut micro-biota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. Redox Biol, 2018, 15:467-479.
[12] Puche JE, García-Fernández M, Muntané J, et al. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology, 2008, 149:2620-2627. |
